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A B S T R A C T
Bone erosion and skull base invasion are often suggestive of a malignant mass in paranasal and nasal
cavities. Nevertheless, forms of chronic rhinosinusitis, such as allergic fungal rhinosinusitis (AFRS), could
mimic malignant features. Here, we report AFRS patient with orbital, anterior cranial fossa, Turkish
saddle and clivus erosion. A 48-year-old Caucasian female with history of drug-resistant headache, nasal
obstruction and anosmia was referred to our institution. Imaging showed hyperdense featureless tissue
with signs of medial orbital wall, cribiform lamina and clivus erosions and encasement of right internal
carotid artery. Massive amounts of thick and grayish mucoid material were evacuated during surgery. In
case of bony erosion, malignancy should always be excluded. Often the correct diagnosis will be obtained
only by operative specimens. AFRS could usually be managed endoscopically. Appropriate medical
management of the AFRS should be administered in order to prevent relapses.
 2012 Elsevier Ireland Ltd. All rights reserved.
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A bone-eroding mass in the nasal cavity and/or paranasal
sinuses should be always investigated in order to exclude a
malignancy. It is important to note however that a chronic, non-
tissue invasive, inﬂammatory process of the nose and paranasal
sinuses, the so called allergic fungal rhinosinusitis (AFRS), could
mimic neoplastic features. It represents an immune hypersensi-
tivity to extramucosal fungal antigens, which leads to the
production and accumulation of allergic mucin. The presentation
of AFRS is usually subtle, consisting of gradually increasing nasal
obstruction, nasal crusting, viscous rhinorrea, and hyposmia.
Unlike bacterial rhinosinusitis, facial or dental pain and headaches
are less common [1,2]. Conversely, multiple nasal polyps are
virtually identiﬁed in all AFRS patients, with unilateral distribution
more common than bilateral [2–4]. The classic and still widely
accepted diagnostic criteria for AFRS were described by Bent and
Kuhn [3], who proposed the following: type 1 hypersensitivity;
nasal polyposis; characteristic computed tomography (CT) scan
ﬁndings; eosinophilic mucus without fungal invasion into sinus
tissue; and a positive fungal stain of evacuated sinus contents. The* Corresponding author at: Academic Clinic of Otolaryngology-Head and Neck
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as allergic mucin accumulates within the paranasal sinuses, it may
form a mucocele and mimic an invasive process. In 6–56% of
patients with AFRS, the expanding mass leads to bony erosion and
involvement of adjacent structures [5]. However, investigators
soon noted that in some cases, the allergic mucin evacuated from
the sinuses did not have identiﬁable fungal elements; these
patients were labeled as having an ‘‘AFRS-like syndrome’’ [6].
Additionally, Ferguson [4] proposed the term ‘‘eosinophilic mucin
rhinosinusitis’’ (EMRS) to describe cases in which fungus was not
identiﬁed histologically. Moreover, she demonstrated that al-
though AFRS and EMRS had identical physical ﬁndings, there were
clinical differences such as acetylsalicylic acid (ASA) sensitivity
was more common in EMRS cases as well as the sinus disease was
exclusively bilateral and asthma was present in nearly all EMRS
patients.
The primary management for both clinical entities was
represented by surgery. The goals of the surgery are:
1. to clear out the edematous mucosa,
2. to create patent sinus ostia large enough to facilitate adequate
drainage and ventilation,
3. to marsupialize involved sinuses.
Although effective at removing large portions of the disease,
surgery is insufﬁcient in eradicating the relentless inﬂammation of
AFRS. In the absence of medical adjuvant therapy, recurrence ratesal rhinosinusitis inﬁltrating anterior skull base and clivus. Auris
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AFRS with anterior skull base and clivus involvement treated by
functional endoscopic sinus surgery (FESS).
2. Case report
A 48-year-old Caucasian female referred to our institution with
a month history of drug-resistant headache, nasal obstruction and
anosmia. Her past medical history was signiﬁcant for ASA
sensitivity and asthma. Sinonasal endoscopy revealed many large
polyps, occluding the nasal cavities, no muco-purulent discharge
nor post nasal dripping as well as no neck masses nor pathologic
lymph nodes were found. The patient underwent a CT scan that
showed hyperdense formless tissue involving all paranasal
sinuses with signs of medial orbital wall erosion, reduction of
ethmoidal cells thickness, massive encasement of right internal
carotid artery in sphenoid sinus, erosion of the cribiform lamina
and clivus (Fig. 1). A contrast-enhanced magnetic resonance
imaging (MRI) was performed in order to clarify the extension of
the mass and to visualize any hypervascularization. This
heterogeneous mass did not appear to invade the dura, the
pituitary gland, the carotid and basilar arteries; furthermore, a
peripheral contrast-enhancement was noted (Fig. 2). The patient
underwent an endoscopic drainage, with the neurosurgical team
on standby in case an open neurosurgical approach was required.
As ﬁrst step biopsies of nasal polyps were obtained and
intraoperatively examined. Inﬂammatory tissue was shown in
all specimens, therefore we performed wide openings of all
paranasal sinuses removing a dense and grayish mucin that
revealed an intact paranasal mucosa. The intraoperative exami-
nation of the mucin demonstrated few eosinophilic cells without
any fungal hyphae. This tenaceous material fulﬁlled each
paranasal sinuses involving the medial orbital wall at both sides;
after its complete removal in sphenoid sinus, a right internal
carotid and optic nerve dehiscences were found. Further, frontalFig. 1. CT scan shows hyperdense formless tissue involving all paranasal sinuses, medial
right internal carotid artery in sphenoid sinus, erosion of the cribiform lamina and cliv
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open approaches were not required. The subsequent pathology
report (Fig. 3) indicated that no fungal elements were visualized
within the tissue; the mucin was described as an amorphous
mucoid material with an extensive collection of eosinophils
and neutrophils, Charcot–Leyden crystals were not identiﬁed
and fungal staining and cultures were negative. Serum levels
of immunoglobulins showed low IgE (238 mg/dL) and a IgG
deﬁciency (523 mg/dL) especially for IgG1 (317 mg/dL). The
patient was discharged with topic corticosteroid therapy and
saline irrigations. At the 3-month follow-up, the patient
had healed completely, the paranasal sinus ostia were well
opened with excellent functional results and no mucin was
present. All of her rhinosinusitis-symptoms had resolved.
3. Discussion
In AFRS-suffering patients, multiple nasal polyps are identiﬁed
with unilateral distribution more common than bilateral [2–4].
Further, in 6–56% of AFRS patients, the expanding mass leads to
bony erosion and involvement of adjacent structures [5]. Although
the erosion may be extensive, it is important to note that the
disease process itself does not invade tissues. Some postulate that
the expanding mucin exerts pressure on neighboring mucosal
blood vessels, thus compromising blood supply to the underlying
bone. Ischemia ensues, weakening bony structures, which become
increasingly susceptible to mechanical stress and necrosis [8]. The
location of the disease, as well as the path of least resistance, will
determine where expansion occurs. Owing to its innate weakness,
the lamina papyracea is the most common location for bony
destruction and the orbit is the most common location for
extrasinus disease spread. When allergic mucin extends into the
orbit, the patient often presents with ocular signs ranging from
proptosis to visual ﬁeld loss [5]. In advanced presentations, lesions
may erode the skull base, leading to intracranial presence of mucin. orbital wall erosion, reduction of ethmoidal cells thickness, massive encasement of
us.
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Fig. 2. MRI excluded invasion of the dura, the pituitary gland and the carotid and basilar arteries by the disomogeneous mass; furthermore, a peripheral contrast-
enhancement was highlighted.
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frontal lobe compression, facial deformity, or even an intracranial
abscess [8]. Initial AFRS management planning includes radio-
graphic imaging. Noncontrast paranasal sinus CT is the preferred
modality, which demonstrates irregular, hyperdense masses
involving multiple sinuses. The most commonly involved are
the ethmoid sinus, followed by the maxillary, frontal, and sphenoid
sinuses. The opaciﬁed sinuses often exhibit small areas of
heterogeneous hyperattenuation, which appear as dots or streaks
in soft tissue windows. These areas of hyperattenuation are
believed to represent accumulated calcium and heavy metal salts
within the allergic mucin. It is possible that fungal elements act as
a nidus for precipitation of the salts. When CT fails to conﬁrm a
clinical picture of AFRS, MRI may be a useful alternative. MRI
reveals masses with decreased or void intensities on T1- and T2-
weighted images, respectively, with sinus mucosa appearing
enhanced [8]. Although CT and MRI ﬁndings are characteristic of
dense extramucosal mucin, they are not speciﬁc to AFRS and can
provide only a presumptive diagnosis. For a deﬁnitive diagnosis of
AFRS, samples of mucin and mucosa must be obtained. It is
essential that specimens be acquired surgically and not with anFig. 3. Amorphous mucoid material with an extensive collection of eosinophils and neu
staining; 2.5 and 5).
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[9]. Histopathologic preparations show mucus peppered with
Charcot–Leyden crystals and eosinophils with variable numbers of
fungal elements, which are best visualized using fungal stains.
Cultures of the mucin mostly grow dermatiaceous fungi such as
Alternaria, Bipolaris, and Curvularia species [3,6,9]. Under the
microscope, sinus mucosal sections demonstrate no evidence of
necrosis, granulomatosis, or fungal invasion [2,9]. However, lacks
evidence of a fungal presence has been reported [4,6]. Ferguson
conducted a retrospective and prospective review of 69 such cases
and coined the idea of EMRS [4]. She found that although AFRS and
EMRS had identical physical ﬁndings, there were statistically
signiﬁcant clinical differences in both groups. The mean age of
AFRS patients was younger (30.7 years) than that of EMRS patients
(48.0 years). Asthma was present in nearly all EMRS patients (93%)
and about half of AFRS patients (41%). ASA sensitivity was much
more common in EMRS cases (54%) than AFRS cases (14%). Sinus
disease was unilateral in 55% of AFRS cases but exclusively bilateral
in EMRS. Total IgE levels were consistently higher for AFRS
patients, and nasal polyps were present in nearly all AFRS and
EMRS patients. These differences suggest that AFRS is likely driventrophils in absence of Charcot–Leyden crystals and fungi (hematoxylin and eosin
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EMRS occurs because of systemic immunologic deregulation.
The idea that EMRS is a systemic entity could explain the high
association with lower airway and bilateral paranasal sinus
pathology. Nevertheless we feel that differences between AFRS
and EMRS are too few to justify the codiﬁcation of a new clinical
entity. Our patient presented some clinical features that satisﬁed
Ferguson’s criteria for EMRS [4]: the patient suffered asthma
with ASA intolerance, was older than 40 years of age and
sierologic analysis demonstrated low levels of IgE with low levels
of IgG subclasses, showed small areas of heterogeneous
hyperattenuation at MRI (Fig. 2). Nevertheless only the term
AFRS has been used in recent review of chronic sinusitis, and
furthermore the presence of extra sinus disease extension shown
by our patient is not listed within Ferguson’s requirements for
EMRS [10–13]. Despite the lack of randomized controlled trials, it
is accepted that the treatment of AFRS and must include surgical
decompression of the sinuses, nasal saline irrigation, and
corticosteroid therapy, either systemic or local. The best clinical
outcomes might be achieved in this way. In our case surgical
treatment with functional endoscopic surgery followed by saline
irrigations and topic administration of corticosteroids proved to
be adequate.
Although effective in removing large portions of the disease,
surgery is insufﬁcient in eradicating the relentless inﬂammation of
AFRS. In the absence of medical adjuvant therapy, recurrence rates
of up to 100% have been reported [2,7]. Unfortunately, randomized
controlled trials have yet to determine optimal doses, duration,
and timing of corticosteroid therapy and whether either oral or
inhalant corticosteroids have different outcomes. In addition to
inﬂammation, atopy and antigen exposure have been targets of
adjuvant therapy. To decrease antigen exposure, two options are
available: irrigation and topical antifungals. Nasal saline irrigation
is very safe and known to be effective in promoting nasal ciliary
clearance reducing intranasal inﬂammatory cytokines; thus, it is
recommended as part of AFRS treatment regimen. Since Bent and
Kuhn [14] demonstrated that fungi, found in AFRS, can be
susceptible to antifungal agents in vitro, antifungal systemic
medications have also been administered in AFRS patients;
however, their utility remains rather controversial in extramucosal
fungal diseases since convincing supportive data are still missing
[2,15].
Finally, despite AFRS could mimic a malignant tumor of
paranasal sinuses with extensive bony erosion encasing vital
structures, the endoscopic approach allows to achieve reason-
able functional results removing all pathologic material and
obtaining full aerated sinuses. It is crucial to exclude any
malignant or invasive fungal disease, therefore mucosal samples
should be intraoperatively analyzed. Although in the majority of
cases the solely endoscopic approach is adequate, a neurosurgi-
cal team should be alerted since an intraoperative diagnosis of
malignancy or invasive fungal disease could require a switch to
a combined endoscopic/open surgical approach in order to
achieve clear resection margins and a suitable reconstruction.Please cite this article in press as: Meccariello G, et al. Allergic fung
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A bone erosing nasal/paranasal sinus mass should always
investigated to exclude a malignancy, although a chronic
inﬂammatory process could be assumed. However, the deﬁnitive
diagnosis of AFRS rests in intraoperative analysis, it is important to
recognize the entity in a clinical setting. Patients presenting with
rhinosinusitis-like symptoms who demonstrate patches of hyper-
attenuation in a background of mucoceles on CT images should be
prime suspects for AFRS. Once a suspicious of chronic inﬂamma-
tory process strongly presumed, the endoscopic surgical treatment
to decompress nasal and paranasal cavities should be performed.
In rare cases, an intracranial neurosurgical team approach could be
necessary to extirpate mucin and to reconstruct bone defects.
Although surgery is very effective, without adjuvant treatment,
recurrence is almost guaranteed. Both oral and inhalant cortico-
steroids have a pivotal role whilst antifungal drugs seems to have
conﬂicting results. Therefore further investigation with random-
ized control trials will be necessary.
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